Explore peptide science, research insights, and emerging discoveries — all in one place.
Research Articles
Content Categories
New Content Added
Always Free Access
Start here. Covers peptide structure, mechanisms of action, terminology, and the core biology every researcher needs before going deeper.
Explore Fundamentals →Deep dives into BPC-157, semaglutide, TB-500, and the peptides generating the most attention in current research literature.
Explore Topics →Mechanism-level breakdowns, peptide comparisons, and research methodology built for investigators who already know the basics.
Explore Guides →Reference guides, glossaries, dosing frameworks, and structured tools to support independent peptide research and study planning.
Explore Tools →BioStrata's own analysis, product quality spotlights, supplier comparisons, and research commentary straight from our team.
Explore Insights →The essential reference for independent researchers — compounds, mechanisms, and protocols in one downloadable PDF. Always free.
Free Research Resource →Research peptides are short chains of amino acids synthesized for laboratory and scientific investigation. They are not drugs or supplements — they are research compounds supplied strictly under a Research Use Only (RUO) framework. See our What Are Research Peptides? guide for a full introduction.
Research peptides exist in a distinct regulatory category from pharmaceuticals. They are legal to purchase for legitimate research purposes in the US under a Research Use Only classification. See our Are Peptides Legal in the United States? article for a detailed breakdown.
BPC-157 is a synthetic peptide studied for its cytoprotective properties. Research has examined its effects on tissue signaling pathways, gastrointestinal function, and cellular repair mechanisms in laboratory settings. See our BPC-157 Research Overview for more detail.
Both are studied in tissue and repair biology research but work through different mechanisms. BPC-157 targets cytoprotective signaling pathways while TB-500 works on actin dynamics and cellular mobility. They are frequently studied together for this reason. See our Peptide Stacks Research Overview, BPC-157 Research Overview, and TB-500 Research Overview for context on how these compounds are studied individually and in combination.
Both semaglutide and tirzepatide are GLP-1 receptor agonists studied for metabolic research, but tirzepatide also targets GIP receptors, making it a dual agonist. Research suggests tirzepatide produces greater average weight reduction in studies.. See our Semaglutide vs Tirzepatide comparison article for more detail.
Peptide Sciences was a major research peptide supplier that shut down operations in 2024, leaving many researchers without a trusted source. BioStrata Research was established to fill that gap with the same commitment to purity and documentation. See our Peptide Sciences Shutdown Analysis for a full breakdown of what happened and what it means for researchers.
Retatrutide is a triple agonist and it activates GLP-1, GIP, and glucagon receptors simultaneously, making it distinct from semaglutide (GLP-1 only) and tirzepatide (GLP-1 + GIP). Phase 3 trial data has shown average weight reductions exceeding 28% at 68 weeks, higher than either compound. It is currently investigational and studied strictly under RUO frameworks. See our Retatrutide Research Overview for a full breakdown, or view the Retatrutide 10mg research compound in our shop.
Stay Ahead of Peptide Research + Get 15% Off
Get regulatory updates, research breakthroughs, and new compound releases — plus 15% off your first order.
Free. No spam. Research and informational context only.
By entering this website you confirm you are at least 21 years of age and acknowledge all products are strictly for laboratory research use only (RUO) and not intended for human or veterinary use.